Dermatomyositis is a disorder that has an inflammatory myopathy that affects the skin together with the muscles. However, it is an autoimmune infection that damages the connective nerves thus weakening the muscles. Tentatively, this condition occurs when someone’s antibodies attacks the healthy cells in the body of a person. Additionally, when an individual has a compromised immune system or an immune that is weak, it increases the chances of the person being infected with dermatomyositis.
Conversely, an individual infected with this disorder shows the following symptoms; unique rashes appearing on the skin, muscle weakness especially on the arm, hip and neck complications that prevents one from doing any hard task, muscle tenderness, unintended weight loss, calcium deposits under the skin, fever and inflammation of the muscles (Szalmảs et al, 2015). However, this condition can be developed by any person especially the adults who are forty years and above. For the case of children, it affects those who are fifteen years and below. It is mostly vulnerable to women compared to men.
Consequently, there is no certain cure for this condition. For the people who are affected, they are advised to undergo physical therapy, surgery and seek expertise medication from a qualified physician in order to improve the condition of their skin and muscles. Furthermore, this condition may be controlled by taking immunosuppressive and corticosteroids drugs. However, some people may resolve completely after undergoing the treatment while others show improved health condition.
In conclusion, M33.91 is a specific ICD-10-CM code that is used to designate a diagnosis for the treatment of dermatomyositis condition. Other related codes include M33.11 and M33.01.